Solutions
Built for every stage of drug development
From early virtual screening to translational PK/PD modeling, DMPK.AI models plug into the decisions your team is already making.
Early discovery
Screen virtual libraries for ADME and CYP liability before synthesis.
Lead optimization
Rank analogs by predicted clearance, exposure, and interaction risk.
DMPK screening
Triage compound sets across the full DMPK endpoint panel in one pass.
Candidate selection
Compare candidates on calibrated, explainable PK and safety-relevant signals.
Translational modeling
Bridge in vitro predictions to projected human PK and PK/PD behavior.
API integration
Embed predictions directly into internal pipelines, ELNs, and screening platforms.
Custom model development
Train endpoint-specific models on your proprietary assay data.